Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu, Cerno Team on Mass Spec Offering

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shimadzu Scientific Instruments and Cerno Bioscience have partnered to offer their respective mass spectrometry systems and analytical software together, Shimadzu said on Monday.

The joint offering includes Shimadzu's LCMS quadrupole systems and Cerno's MassWorks software, which researchers identifying compounds can use together to improve mass accuracy, the company said.

Researchers can use the integrated solution, which employs Cerno's DirectRead technology, to open and process data from Shimadzu's LCMS-2010, LCMS-2020, and LCMS-IT-TOF spectrometers.

Shimadzu said that this capability enables users to save time, reduce transcription errors, simplify files management, and save disk space.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.